Stephen Uden
CIK 1332141 · Chief Executive Officer · last filed 2025-02-19
Stephen Uden is a Chief Executive Officer who has filed 6 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for RLYB, was dated Feb 19, 2025. Across all open-market trades the lifetime net is +$98.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $11.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.44M
2
6
$98.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RLYB | Chief Executive Officer | 718,320 | $15.92 | $11.44M | $98.5K | 5 | 2025-02-19 |
| NEUROGEN CORP (NRGN) Delisted | Exec VP, Research & Developmen | — | — | — | $0 | 1 | 2007-01-19 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-19 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2024-02-16 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2023-02-06 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2022-02-09 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2022-01-14 | RLYB | Mixed | +719,127 | $98.5K | EDGAR |
| 2007-01-19 | NEUROGEN CORP (NRGN) Delisted | Grant (A) | — | $0 | EDGAR |